Cargando…

Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria

BACKGROUND: The World Health Organization (WHO) in 2015 stated atovaquone‐proguanil can be used in travellers, and is an option in malaria‐endemic areas in combination with artesunate, as an alternative treatment where first‐line artemisinin‐based combination therapy (ACT) is not available or effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanshard, Andrew, Hine, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094970/ https://www.ncbi.nlm.nih.gov/pubmed/33459345 http://dx.doi.org/10.1002/14651858.CD004529.pub3

Ejemplares similares

Plasmodium falciparum Malaria and Atovaquone-Proguanil Treatment Failure
por: Durand, Rémy, et al.
Publicado: (2008)

Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases
por: Cordel, Hugues, et al.
Publicado: (2013)

Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast
por: Wurtz, Nathalie, et al.
Publicado: (2012)

The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
por: Maude, Richard J, et al.
Publicado: (2014)

Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil
por: Sutherland, Colin J, et al.
Publicado: (2008)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2019)

Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola
por: Pimentel, Sónia, et al.
Publicado: (2006)

Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa
por: Happi, Christian T, et al.
Publicado: (2006)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2022)

Amplicon Deep Sequencing Reveals Multiple Genetic Events Lead to Treatment Failure with Atovaquone-Proguanil in Plasmodium falciparum
por: Castañeda-Mogollón, Daniel, et al.
Publicado: (2023)

Atovaquone/proguanil‐induced autoimmune‐like hepatitis
por: Terziroli Beretta‐Piccoli, Benedetta, et al.
Publicado: (2017)

Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb
por: Teo, Beatrix Huei-Yi, et al.
Publicado: (2015)

In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand
por: Khositnithikul, Rommanee, et al.
Publicado: (2008)

Tolerability of Atovaquone—Proguanil Application in Common Buzzard Nestlings
por: Wiegmann, Anja, et al.
Publicado: (2022)

Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis
por: Staines, Henry M, et al.
Publicado: (2018)

A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria
por: Laufer, Miriam K., et al.
Publicado: (2012)

Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis
por: Nicosia, V, et al.
Publicado: (2008)

A survey on outcomes of accidental atovaquone–proguanil exposure in pregnancy
por: Tan, Kathrine R., et al.
Publicado: (2018)

A Safe and Effective Atovaquone-Proguanil Therapeutic Protocol for the Treatment of Avian Malaria by Plasmodium relictum in Snowy Owl (Bubo scandiacus)
por: Pugliese, Nicola, et al.
Publicado: (2023)

Novel Mutation in Cytochrome B of Plasmodium falciparum in One of Two Atovaquone-Proguanil Treatment Failures in Travelers Returning From Same Site in Nigeria
por: Plucinski, Mateusz M., et al.
Publicado: (2014)

Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone
por: Skinner-Adams, Tina S., et al.
Publicado: (2019)

Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis
por: Tommasi, Chiara, et al.
Publicado: (2011)

Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone–proguanil in traveller returning from Congo
por: Massamba, Laurencie, et al.
Publicado: (2020)

Dihydroartemisinin‐piperaquine for treating uncomplicated Plasmodium falciparum malaria
por: Zani, Babalwa, et al.
Publicado: (2014)

Artemisinin‐naphthoquine for treating uncomplicated Plasmodium falciparum malaria
por: Isba, Rachel, et al.
Publicado: (2015)

Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria
por: Bukirwa, Hasifa, et al.
Publicado: (2014)

Proguanil and atovaquone use is associated with lower colorectal cancer risk: a nationwide cohort study
por: Zhang, Naiqi, et al.
Publicado: (2022)

Transmissibility of clinically relevant atovaquone-resistant Plasmodium falciparum by anopheline mosquitoes
por: Balta, Victoria A., et al.
Publicado: (2023)

Unanticipated CNS Safety Signal in a Placebo‐Controlled, Randomized Trial of Co‐Administered Atovaquone‐Proguanil and Amodiaquine
por: Chalon, Stephan, et al.
Publicado: (2021)

Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
por: Ehrhardt, Stephan, et al.
Publicado: (2009)

Human Gene Expression in Uncomplicated Plasmodium falciparum Malaria
por: Colborn, James M., et al.
Publicado: (2015)

Severe atovaquone-resistant Plasmodium falciparum malaria in a Canadian traveller returned from the Indian subcontinent
por: Perry, Thomas L, et al.
Publicado: (2009)

Estimation of the In Vivo MIC of Cipargamin in Uncomplicated Plasmodium falciparum Malaria
por: Hien, Tran Tinh, et al.
Publicado: (2017)

The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum
por: Chotivanich, Kesinee, et al.
Publicado: (2012)

Molecular basis of extreme resistance in Plasmodium falciparum to atovaquone and other mitochondrial inhibitors
por: Siegel, Sasha, et al.
Publicado: (2014)

Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
por: Osorio, Lyda, et al.
Publicado: (2007)

Pharmacokinetics of Piperaquine in Pregnant Women in Sudan with Uncomplicated Plasmodium falciparum Malaria
por: Adam, Ishag, et al.
Publicado: (2012)

Comparison of parasite sequestration in uncomplicated and severe childhood Plasmodium falciparum malaria()
por: Cunnington, Aubrey J., et al.
Publicado: (2013)

Immunoglobulin response to Plasmodium falciparum RESA proteins in uncomplicated and severe malaria
por: Badaut, Cyril, et al.
Publicado: (2015)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
por: Ghimire, Prakash, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lnibacqtukfqi8fjmjahqgkv0i